Join to access to all OVN content. Join for Free
Why Go ALONE? How 2 Aspiring MSLs Reached Their Goal TOGETHER
MSL roles collaboration strategies job search tactics aspiring MSLs mentorship importance

Why Go ALONE? How 2 Aspiring MSLs Reached Their Goal TOGETHER


Share This Article


Summary

In this episode, Tom Caravela is joined by Sierra Birch and George Lehman to discuss the power of collaboration in securing MSL roles. Celebrating a milestone of nearly 250,000 listeners, the episode explores Sierra and George's professional journeys and their organic partnership. They share strategies and beneficial practices for landing MSL positions, while also addressing challenges and ineffective approaches. The conversation highlights the importance of mentors and outlines key requirements for aspiring MSLs. Concluding with a speed round of advice, the episode offers encouragement and appreciation for the audience.

My guests are George Limen, Medical Liaison at Novo Nordisk and Cierra Birch, Molecular Science Liaison with Caris Life Science and discuss how they collaborated to land their first MSL positions
We discuss….

๐Ÿ‘‰ How they joined forces to find success in their job searches
๐Ÿ‘‰ What were some of the most impactful tactics in the process
๐Ÿ‘‰ What challenges they faced along the way
๐Ÿ‘‰ How they dealt with frustration and discouragement
๐Ÿ‘‰ What were the absolute MUSTs for these efforts

Click for Source
MSL roles, collaboration strategies, job search tactics, aspiring MSLs, mentorship importance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
No โ€œDโ€โ€ฆNo Problem: Finding Success WITHOUT a Doctorate
Partner Avatar MSL Talk: Tom Caravela, Greg Auclair

No โ€œDโ€โ€ฆNo Problem: Finding Success WITHOUT a Doctorate

Podcast
Role of the MSL in launch preparedness for new products and indications
Partner Avatar MSL Talk: Tom Caravela, Matt Goodwin

Role of the MSL in launch preparedness for new products and indications

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%โ€‹
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%โ€‹

Explore OVN